Comparison of Ultrasound-Guided Serratus Combination Plane Blocks and Local Wound Infiltration for Postoperative Analgesia Management in Minimally Invasive Cardiac Surgery (MICS)
İstanbul Yeni Yüzyıl Üniversitesi
60 participants
Oct 17, 2024
INTERVENTIONAL
Conditions
Summary
This randomized, prospective, single-blinded study aims to compare the efficacy of ultrasound-guided serratus anterior plane (SAP) block combined with serratus-intercostal interfascial plane (SIP) block versus local wound infiltration (LWI) for postoperative analgesia in patients undergoing minimally invasive cardiac surgery (MICS). The primary outcome is total perioperative and postoperative opioid consumption. Secondary outcomes include postoperative pain scores (NRS), opioid-related side effects, block-related complications, and ICU stay duration.
Eligibility
Inclusion Criteria4
- Age 18-75 years
- Undergoing MICS with left-sided 4th-5th intercostal incision
- ASA I-III
- Informed consent provided
Exclusion Criteria6
- Coagulopathy or on anticoagulants
- Allergy to local anesthetics or opioids
- Local infection at block site
- Pregnancy or lactation
- Bilateral thoracic incisions
- Refusal to participate
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants will receive an ultrasound-guided serratus anterior plane (SAP) block using 30 mL of 0.25% bupivacaine combined with a serratus-intercostal interfascial plane (SIP) block using 10 mL of 0.25% bupivacaine. Both blocks will be administered after surgery but before emergence from anesthesia. This combination targets multiple interfascial planes to enhance postoperative analgesia in patients undergoing minimally invasive cardiac surgery (MICS).
Participants will receive local wound infiltration with 40 mL of 0.25% bupivacaine applied to the surgical and drain sites following surgery. This approach represents a standard method for managing postoperative pain in MICS patients and serves as the active comparator.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06968065